Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 333 for “"MDM2"”.
-
Allosteric regulation of MDM2 protein
The diverse functions of the MDM2 oncoprotein in growth control and tumourigenesis are managed through coordinated regulation of its discrete domains induced by both extrinsic and intrinsic stimuli. A picture of MDM2 is immerging where structurally discrete but interdependent functional domains are …
-
Novel concepts in mdm2 protein regulation
The tumour suppressor p53 has evolved a MDM2-dependent feedback loop that has a dual role as either a stimulator of p53 protein translation through mRNA binding or a stimulator of p53 protein degradation through the ubiquitin-proteasome system. A unique pseudo-substrate motif or “lid” in MDM2 is …
-
Role of MDM2 In Cell Growth Regulation
MDM2 has been shown to induce G0-Gl/S phase arrest. To determine the cell cycle step targeted by MDM2, flow cytometry was employed to detect induction of events during the G1-S phase transition in MDM2-arrested cells. MDM2 overexpression does not prevent expression of cyclin D, cyclin D-CDK …
-
Targeting the p53/MDM2 protein-protein interaction
The p53/MDM2 protein-protein interaction is the most widely characterised proteinprotein interaction to date. As of 2014, there are over 20 compounds that have been shown to the p53-MDM2 protein-protein interaction, however many compounds have not progressed into clinical trials due to their high …
-
Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a
Nutlin-3a is an MDM2-p53 interaction antagonist that is under investigation in preclinical models for a variety of pediatric malignancies, including neuroblastoma, retinoblastoma, leukemia, and rhabdomyosarcoma. In the current research, we conducted preclinical pharmacology studies of nutlin-3a to …
-
Regulation of p53 by catalytically-inactive MDM2 mutants
MDM2-MDMX complexes bind to p53, inhibiting the p53 transcriptional activity and targeting p53 for proteasomal degradation. Uncoupling p53 from MDM2 is therefore an attractive strategy to treat cancers that retain wild type p53. Small molecules that inhibit MDM2 binding to p53 release p53 from …
-
Crosstalk Between MDM2 and Akt Signaling Pathway in Oncogenesis.
MDM2, the human homologue of the Mouse Double Minute 2 gene product, has been shown to be over-expressed in many cancers and to induce tumorigenesis. The role of MDM2 in oncogenesis was thought to be p53 dependent. However recent years have shown MDM2 to be a key player in a complex network of …
-
Therapeutic Efficacy of P53 Restoration In Mdm2-Overexpressing Tumors
… p53. Other mechanisms, e.g. upregulation of Mdm2 levels, exist in tumors to inactivate the p53 pathway. Mdm2, an E3 ubiquitin-ligase that targets p53 for proteasomal degradation, is present at high levels in many tumors with wild-type p53. In this study, we probed the effects of restoring p53 …
-
NOVEL FUNCTIONS OF TUMOR SUPPRESOR P14ARF AND PROTO-ONCOPROTEIN MDM2
… of at least one member of the p14ARF (ARF)-MDM2-p53 axis. This thesis reports novel functions of ARF and MDM2. ARF is lost in 40% of cancers and plays a significant role in the innate immune response. However, the mechanism is unclear. ARF is also an enhancer of protein SUMOylation. I …
-
REGULATION OF MDM2 MEDIATED NFκB2 PATHWAY IN HUMAN LUNG CANCER
Overexpression of oncoprotein MDM2 and mutations of tumor suppressor p53 are frequently observed in human cancers. The NFκB pathway is one of the deregulated pathways in oncogenesis. The overall goal of the project was to study the regulation of NFκB pathway by MDM2 in lung cancer. Our first effort …
-
Characterization of the MDM2 binding regions of ribosomal protein L5
The MDM2-p53 feedback loop is a well-characterized pathway. p53 is a transcription factor and regulates the transcriptional expression of genes that encode proteins responsible for cellular senescence, cell cycle arrest, apoptosis, and DNA repair. Various cellular stresses can result in p53 …
-
The Consequences of Disrupting The Mdm2-P53 Balance In Hematopoiesis
… a hypomorphic p53 allele in the absence of Mdm2, a p53 inhibitor, have elevated p53 cell cycle activity and die by postnatal day 13 due to hematopoietic failure. Hematopoiesis progresses normally during embryogenesis until it moves to the bone marrow in late development. Increased oxidative …
-
Contrasting Effects of An Mdm2 Functional Polymorphism On Tumor Phenotypes
… functional polymorphisms with cancer risk. The MDM2 SNP309G allele is a cancer-associated functional polymorphism positioned in the MDM2 P2 promoter that enhances transcription factor SP1 binding, resulting in elevated levels of MDM2 concomitant with decreased p53 tumor-suppressor activity. …
-
Regulation of FOXO Stability and Activity by MDM2 E3 Ligase
… be defined. The current studies demonstrate that MDM2 bound to FOXO1 and FOXO3A and promoted their ubiquitination and subsequent degradation, a process apparently dependent on FOXO phopshorylation at PKB sites and on the E3 ligase activity of MDM2. The binding occurred between endogenous proteins …
-
Dual inhibition of BRD4 and MDM2 cooperate to eradicate AML
… functionally deficient by over-expression of MDM2. Restoring the TP53 response though MDM2 antagonism is therefore potentially beneficial to most AML subtypes. We therefore hypothesized that dual inhibition of MDM2 and BET would be synthetic lethal to TP53 wild type AML. In comparison with the …
-
Regulation of MDM2 and the p53 Family by the NEDD8 Pathway
… been identified as NEDD8 substrates, including MDM2 and p53. MDM2 is an oncogenic E3 ligase that promotes NEDD8 modification and ubiquitin-mediated degradation of the tumor suppressor transcription factor, p53. Cellular stresses such as DNA damage lead to p53 activation due, in part, to MDM2 …
Page 1 of 17